6887 — Sunshine Lake Pharma Co Balance Sheet
0.000.00%
- HK$32.96bn
- HK$38.00bn
- CNY4.02bn
Annual balance sheet for Sunshine Lake Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 1,262 | 1,920 | 1,485 |
Net Total Accounts Receivable | |||
Net Total Receivables | 2,274 | 2,018 | 1,894 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 4,151 | 6,412 | 4,979 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 4,003 | 4,180 | 4,391 |
Net Intangible Assets | |||
Long Term Investments | |||
Other Long Term Assets | |||
Total Assets | 10,689 | 12,658 | 11,932 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 8,958 | 6,178 | 4,814 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 14,378 | 12,330 | 11,587 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Treasury Stock | |||
Other Equity | |||
Total Equity | -3,689 | 328 | 344 |
Total Liabilities & Shareholders' Equity | 10,689 | 12,658 | 11,932 |
Total Common Shares Outstanding |